CEO Rohan Greenland shares five areas of special interest he’s watching closely as the world’s largest MS research congress, ECTRIMS, takes place in Barcelona….
In this Q&A, Associate Professor Litza Kiropoulos discusses the connection between MS and mental health and her MS Australia-supported research aimed at improving quality of life….
Updated international guidelines for diagnosing multiple sclerosis (MS) were published today, enabling earlier and more accurate diagnosis so people can begin treatment sooner and improve their long-term health outcomes….
CEO Rohan Greenland details the upcoming handover of the Blueprint for a National Action Plan for Neurological Conditions, a prod to government to recognise both the obligation and the economic…
A new Australian study shows COVID-19 boosters improve protection against new variants for people with MS, even when taking immune-suppressing treatments….
The Pharmaceutical Benefits Advisory Committee has recommended subcutaneous ocrelizumab (Ocrevus®) be listed on the PBS for treating relapsing remitting MS….
The Government has announced changes to the NDIS aimed at slowing growth and making the scheme more sustainable. What are those changes and how will they impact Australians living with…